Patients undergoing re-operative cardiac surgical procedures present a great challenge with regard to obtaining hemostasis in the surgical field. Adhesions are ever-present and these patients are often on oral anti-coagulants and platelet inhibitors. As part of a well-planned surgical intervention, a systematic approach to hemostasis should be employed to decrease blood transfusion requirement and improve patient outcomes. Topical hemostatic agents can be a great help tothe surgeon in achieving surgical field hemostasis and are increasingly being employed. Our approach, to these difficultpatients, includes the systematic and planned use of AristaAH, which is a novel hemostatic agent whose use has proven safe and efficacious in our patient population.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Jan 1 2012|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine